# Trade Mark Journal No.2025/044 31 October 2025

## WO0000001881533 (1,5)

Office of origin: United States of America

Date of International Registration:26 August 2025
Date of designation in the UK: 26 August 2025

International priority date claimed: 17 March 2025 (United States of America) (99087192)

Class 1
  Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely buffer solutions, used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory and research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning.
Class 5
  Diagnostic preparations for medical and veterinary purposes, namely diagnostics preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes.

QIAGEN Beverly, LLC

Representative: Randolph E Digges, III Rankin, Hill & Clark LLP, P.O. Box 1150, Bonita Springs FL 34133-1150, UNITED STATES OF AMERICA